Browse by Series:

Delayed FDA Filing for Neratinib, Halting of Potential PSA-Screening Penalty, New CEO for ASCO, and More

Gina Columbus
Published: Friday, Apr 01, 2016

Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication